new glp 1 drugs in development Emerging Weight Loss and What Pharmacies Need to Know The New York Times spotlighted
Description
Endogenous GLP-1 affects postprandial blood glucose by slowing gastric emptying and glucose absorption in healthy subjects (Schirra et al., 2006)
Posted on behalf of
1 The neuroprotection of glucagon like peptide-1 receptor agonists in neurodegenerative and cerebrovascular disorders Glucagon like peptide-1 (GLP-1) is a peptide called enteropancreatin secreted by small intestinal L cells
This widespread distribution means GLP-1 affects multiple systems simultaneously
GLP-1 medications support liver health by reducing liver fat accumulation, decreasing inflammation, and improving liver function
Liao C, Liang X, Zhang X, Li Y
